Impact of nodular calcification in patients with acute coronary syndrome (ACS) treated with primary percutaneous coronary intervention (PCI)

Table 1 Baseline characteristics of patients

Variables	Nodular (n = 236)	Non- nodular (n = 259)	p value
Patients characteristics
Age, years	63.8 ± 10.1	59.6 ± 10.0	< 0.001
Gender
Male	146 (61.9%)	164 (63.3%)	0.738
Female	90 (38.1%)	95 (36.7%)
Hypertension	125 (53%)	136 (52.5%)	0.919
Diabetes mellitus	59 (25%)	59 (22.9%)	0.579
Hyperlipidemia	52 (22.3%)	57 (22%)	0.934
Current smoker	100 (44.1%)	121 (48%)	0.385
Estimated GFR < 60 mL/min/1.73m²	10 (4.3%)	7 (2.7%)	0.340
Previous MI	16 (6.8%)	17 (6.6%)	0.903
Previous CABG	-	-	-
Previous PCI	10 (4.3%)	13 (5%)	0.703
Clinical presentation
STEMI	182 (77.1%)	199 (76.8%)	0.940
NSTEACS	54 (22.9%)	60 (23.2%)
Laboratory findings
WBC count, × 10³/L	10.9 ± 3.2	11.8 ± 10.2	0.244
TC, mg/dL	170.9 ± 42.6	174.8 ± 38.4	0.318
TG, mg/dL	52.1 ± 28.4	60.2 ± 39.7	0.015
LDL-C, mg/dL	106.2 ± 34.4	111.1 ± 32.6	0.133
HDL-C, mg/dL	49.0 ± 11.2	47.7 ± 11.1	0.223
HbA_1C, %	6.5 ± 1.7	6.3 ± 1.3	0.668
Hs-CRP, mg/dL	6.4 ± 5.2	6.5 ± 4.6	0.953
Peak CK-MB, U/L	215.6 ± 221.6	206.8 ± 222.2	0.684
Echocardiographic data
LVEF, %	57.3 ± 6.5	58.5 ± 6.2	0.045

Values are mean ± SD or median (25–75th percentiles) or n (%)
GFR, glomerular filtration rate; MI, myocardial infarction; CABG, coronary artery bypass graft; PCI, percutaneous coronary intervention; STEMI, ST-segment elevation myocardial infarction; NSTEACS, non-ST-segment elevation acute coronary syndrome; TC, total cholesterol; TG, triglyceride; LDL-C, low-density lipoprotein cholesterol; HDL-C, high-density lipoprotein cholesterol; HbA_1C, hemoglobin; hs-CRP, high-sensitive C-reactive protein; CK-MB, creatine kinase-MB; LVEF, left ventricular ejection fraction

ISSN: 1471-2261